In a recent study published in the journal Current Medical Research and Opinion, researchers report that high lipoprotein(a) levels were linked to repeated coronary heart disease events in older ...
There is an association between genetically predicted increased insulin concentrations and decreased concentrations of circulating lipoprotein(a) (Lp[a]), according to a study published online Aug. 29 ...
BACKGROUND: Although the effectiveness of Lp(a) (lipoprotein[a])–lowering therapies remains under study, lipid guidelines now ...
Please provide your email address to receive an email when new articles are posted on . High levels of lipoprotein(a) are associated with elevated risk for an adverse heart event. The relationship was ...
Elevated lipoprotein(a) levels can slowly block the arteries, increasing the likelihood of cardiovascular disease. Since no treatment is currently available for this condition, it is essential to ...
Muvalaplin, an oral, once-daily treatment that inhibits lipoprotein(a) formation via a novel mechanism, achieved positive results in a 12-week Phase 2 study These data were published in the Journal of ...
Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women. Elevated plasma lipoprotein(a) is a ...
In adults without prior coronary artery disease at the time of imaging, elevated lipoprotein(a) (Lp[a]) levels (≥ 150 nmol/L) were independently associated with increased non-calcified plaque volume ...
A recent study published in the Virology Journal has highlighted the significance of high-density lipoprotein (HDL) in coronavirus disease 2019 (COVID-19) pathogenesis and outcome. A severely low ...